Komipharm International Co. Ltd (041960) — Cash Flow-to-Debt Ratio
Komipharm International Co. Ltd (041960) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of ₩946.94 Million could theoretically repay 0% of its total liabilities (₩61.86 Billion) in one year. See Komipharm International Co. Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Komipharm International Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Komipharm International Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see 041960 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Komipharm International Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for Komipharm International Co. Ltd. Check Komipharm International Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ₩-621.80 Million | ₩61.86 Billion | ▼ -106.5% |
| 2024 | 0.15x | ₩8.85 Billion | ₩57.23 Billion | ▲ +423.5% |
| 2023 | -0.05x | ₩-2.80 Billion | ₩58.58 Billion | ▼ -35.1% |
| 2022 | -0.04x | ₩-1.81 Billion | ₩51.12 Billion | ▼ -37.4% |
| 2021 | -0.03x | ₩-1.26 Billion | ₩48.80 Billion | ▼ -4760.6% |
| 2020 | 0.00x | ₩25.20 Million | ₩45.64 Billion | ▼ -97.0% |
| 2019 | 0.02x | ₩950.79 Million | ₩52.37 Billion | ▲ +141.9% |
| 2018 | -0.04x | ₩-2.02 Billion | ₩46.52 Billion | ▼ -983.6% |
| 2017 | 0.00x | ₩235.64 Million | ₩48.00 Billion | ▼ -77.0% |
| 2016 | 0.02x | ₩1.21 Billion | ₩56.64 Billion | ▲ +141.7% |
| 2015 | -0.05x | ₩-2.93 Billion | ₩57.26 Billion | ▼ -43.7% |
| 2014 | -0.04x | ₩-2.54 Billion | ₩71.24 Billion | ▼ -158.0% |
| 2013 | 0.06x | ₩3.93 Billion | ₩64.08 Billion | — |